Commission Implementing Regulation (EU) 2025/2503 of 11 December 2025 concerning the authorisation of a preparation of endo-1,4-beta-xylanase, endo-1,4-beta-glucanase and xyloglucan-specific-endo-beta-1,4-glucanase produced with Trichoderma citrinoviride DSM 33578 as a feed additive for poultry other than poultry for fattening, poultry reared for laying and reared for breeding and porcine species other than sows of all Suidae species (holder of authorisation: Huvepharma EOOD)
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
I Veterinary and Phytosanitary Matters
I.II Feedingstuffs
Joint committee decision (JCD)
062/2026
In force in the EEA
Yes
Legal Documents
Commission Implementing Regulation (EU) 2025/2503 of 11 December 2025 concerning the authorisation of a preparation of endo-1,4-beta-xylanase, endo-1,4-beta-glucanase and xyloglucan-specific-endo-beta-1,4-glucanase produced with Trichoderma citrinoviride DSM 33578 as a feed additive for poultry other than poultry for fattening, poultry reared for laying and reared for breeding and porcine species other than sows of all Suidae species (holder of authorisation: Huvepharma EOOD)
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2025/2503 frá 11. desember 2025 um leyfi fyrir blöndu með endó-1,4-betaxýlanasa, endó-1,4-betaglúkanasa og xýlóglúkansértækum endó-beta-1,4-glúkanasa, sem eru framleiddir með Trichoderma citrinoviride DSM 33578, sem fóðuraukefni fyrir alifugla, aðra en alifugla til eldis, alifugla sem eru aldir til varps og til undaneldis og fyrir svínategundir, aðrar en gyltur af öllum svínategundum (leyfishafi er Huvepharma EOOD)
Durchführungsverordnung (EU) 2025/2503 der Kommission vom 11. Dezember 2025 zur Zulassung einer Zubereitung aus Endo-1,4-beta-Xylanase, Endo-1,4-beta-Glucanase und xyloglucanspezifischer Endo-beta-1,4-Glucanase, hergestellt mit Trichoderma citrinoviride DSM 33578, als Zusatzstoff in Futtermitteln für Geflügel ausgenommen Mastgeflügel, Jungtiere aller Geflügelarten für Lege- oder Zuchtzwecke und Schweine ausgenommen Sauen aller Suidae-Arten (Zulassungsinhaber: Huvepharma EOOD)
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.